Want to see AAPG full AI Analyst Report?
Ascentage Pharma Group International Unsponsored ADR (AAPG) Financial Statements
Ascentage Pharma Group International Unsponsored ADR Financial Overview
Ascentage Pharma Group International Unsponsored ADR's market cap is currently $1.29B. The company's EPS TTM is $-15.60; its P/E ratio is -5.86; Ascentage Pharma Group International Unsponsored ADR is estimated to report earnings on March 31, 2027, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 558.48M | $ 980.65M | $ 221.98M | $ 209.71M | $ 27.91M |
| Gross Profit | $ 426.75M | $ 951.57M | $ 191.44M | $ 187.71M | $ 24.58M |
| Operating Income | $ -1.18B | $ -369.73M | $ -872.64M | $ -849.81M | $ -869.84M |
| EBITDA | $ -1.09B | $ -237.63M | $ -743.61M | $ -771.47M | $ -787.19M |
| Net Income | $ -1.21B | $ -405.43M | $ -925.64M | $ -882.92M | $ -782.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.47B | $ 1.24B | $ 1.07B | $ 1.48B | $ 1.71B |
| Total Assets | $ 3.97B | $ 2.62B | $ 2.50B | $ 2.83B | $ 2.94B |
| Total Debt | $ 1.98B | $ 1.67B | $ 1.80B | $ 1.79B | $ 1.08B |
| Net Debt | $ -490.68M | $ 431.92M | $ 726.30M | $ 317.09M | $ -622.60M |
| Total Liabilities | $ 2.63B | $ 2.34B | $ 2.43B | $ 2.42B | $ 1.71B |
| Stockholders' Equity | $ 1.33B | $ 264.19M | $ 60.42M | $ 408.66M | $ 1.23B |
| Cash Flow | |||||
| Free Cash Flow | $ -1.20B | $ -135.65M | $ -782.92M | $ -890.88M | $ -1.04B |
| Operating Cash Flow | $ -1.17B | $ -111.36M | $ -726.08M | $ -653.91M | $ -604.68M |
| Investing Cash Flow | $ -1.00B | $ -362.04M | $ 21.92M | $ -384.61M | $ -466.52M |
| Financing Cash Flow | $ 2.54B | $ 314.77M | $ 368.75M | $ 619.27M | $ 1.78B |
Currency in CNY
